Multiple roles of the candidate oncogene ZNF217 in ovarian epithelial neoplastic progression

No abstract is available for this paper.

• Publication year

  2007

• Venue

  International Journal of Cancer

• Publication date

  2007-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.22300PMID 17266044
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• What has senescence got to do with cancer?

  2005cited by this paper
• Coexistence of Copy Number Changes of Different Genes (INK4A, erbB-1, erbB-2, CMYC, CCND1 and ZNF217) in Urothelial Tumors

  2005cited by this paper
• ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction.

  2005cited by this paper
• Expression and nuclear location of the transcriptional repressor Kaiso is regulated by the tumor microenvironment.

  2005cited by this paper
• Gene copy number change events at chromosome 20 and their association with recurrence in gastric cancer patients.

  2005cited by this paper
• Detection of Her2/neu, c-MYC and ZNF217 gene amplification during breast cancer progression using fluorescence in situ hybridization.

  2005cited by this paper
• Effects of Epidermal Growth Factor/Hydrocortisone on the Growth and Differentiation of Human Ovarian Surface Epithelium

  2004cited by this paper
• A Genetically Defined Model for Human Ovarian Cancer

  2004cited by this paper
• Rapid Inhibition of Cancer Cell Growth Induced by Lentiviral Delivery and Expression of Mutant-Template Telomerase RNA and Anti-telomerase Short-Interfering RNA

  2004cited by this paper
• The candidate oncogene ZNF217 is frequently amplified in colon cancer

  2004cited by this paper
• Identification of 27 5′ CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers

  2004cited by this paper
• The role of transforming growth factor alpha in determining growth factor independence.

  2003cited by this paper
• Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

  2003cited by this paper
• The Role of Transforming Growth Factor in Determining Growth Factor Independence

  2003cited by this paper
• Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma.

  2003cited by this paper
• Specific keynote: genome copy number abnormalities in ovarian cancer.

  2003cited by this paper
• Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high‐resolution microarray comparative genomic hybridization

  2003cited by this paper
• Induction of plasminogen activator inhibitor-2 is associated with suppression of invasive activity in TPA-mediated differentiation of human prostate cancer cells.

  2003cited by this paper
• Autocrine laminin-5 ligates 6 4 integrin and activates RAC and NF B to mediate anchorage-independent survival of mammary tumors

  2003cited by this paper
• Extensive allelic variation and ultrashort telomeres in senescent human cells

  2003cited by this paper
• Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium.

  2003cited by this paper
• Immortalisation of human ovarian surface epithelium with telomerase and temperature-sensitive SV40 large T antigen.

  2003cited by this paper
• Shaping of tumor and drug-resistant genomes by instability and selection

  2003cited by this paper
• Roles of luteinizing hormone/chorionic gonadotropin receptor in anchorage‐dependent and ‐independent growth in human ovarian surface epithelial cell lines

  2003cited by this paper
• Simian Virus 40 Small Tumor Antigen Activates AKT and Telomerase and Induces Anchorage-Independent Growth of Human Epithelial Cells

  2002cited by this paper
• Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation.

  2002cited by this paper
• CAS (cellular apoptosis susceptibility) gene expression in ovarian carcinoma: Correlation with 20q13.2 copy number and cyclin D1, p53, and Rb protein expression.

  2002cited by this paper
• Fully automatic quantification of microarray image data.

  2002cited by this paper
• Differentially Regulated Genes as Putative Targets of Amplifications at 20q in Ovarian Cancers

  2002cited by this paper
• Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer

  2002cited by this paper
• Cytokines modulate telomerase activity in a human multiple myeloma cell line.

  2002cited by this paper
• Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft.

  2002cited by this paper
• Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway

  2002cited by this paper
• Ovarian surface epithelium: biology, endocrinology, and pathology.

  2001cited by this paper
• The ZNF217 gene amplified in breast cancers promotes immortalization of human mammary epithelial cells.

  2001influential reference
• Assembly of microarrays for genome-wide measurement of DNA copy number

  2001influential reference
• Comprehensive genome sequence analysis of a breast cancer amplicon.

  2001cited by this paper
• Down-regulation of the desmosomal cadherin desmocollin 3 in human breast cancer.

  2001cited by this paper
• Matrix-independent survival of human keratinocytes through an EGF receptor/MAPK-kinase-dependent pathway.

  2001cited by this paper
• Differences in 20q13.2 copy number between colorectal cancers with and without liver metastasis.

  2000cited by this paper
• Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis.

  2000cited by this paper
• Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer.

  2000cited by this paper
• PIK3CA is implicated as an oncogene in ovarian cancer

  1999cited by this paper
• Regulation of proliferation and apoptosis by epidermal growth factor and protein kinase C in human ovarian surface epithelial cells.

  1999cited by this paper
• Dominant genetic alterations in immortalization: Role for 20q gain

  1999cited by this paper
• Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma.

  1998cited by this paper
• Tumor and endothelial cell invasion of basement membranes. The matrigel chemoinvasion assay as a tool for dissecting molecular mechanisms.

  1998cited by this paper
• 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells

  1997cited by this paper
• Simian virus 40-transformed human ovarian surface epithelial cells escape normal growth controls but retain morphogenetic responses to extracellular matrix.

  1992influential reference
• FUGE: an analytical ultracentrifuge simulation for teaching purposes

  1988cited by this paper
• Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract.

  1984cited by this paper

• The implications of N6-methyladenosine (m6A) modification in esophageal carcinoma

  2023cites this paper
• ZNF217: the cerberus who fails to guard the gateway to lethal malignancy.

  2021influential citation
• Decreased Expression of NUSAP1 Predicts Poor Overall Survival in Cervical Cancer

  2020cites this paper
• The AKT inhibitor triciribine in combination with paclitaxel has order-specific efficacy against Zfp217-induced breast cancer chemoresistance

  2017cites this paper
• Comparative transcriptome analysis links distinct peritoneal tumor spread types, miliary and non-miliary, with putative origin, tubes and ovaries, in high grade serous ovarian cancer.

  2017cites this paper
• Effects of ZNF139 on gastric cancer cells and mice with gastric tumors

  2016cites this paper
• GATA3-driven expression of miR-503 inhibits prostate cancer progression by repressing ZNF217 expression.

  2016cites this paper
• The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value

  2015influential citation
• Coordination of m(6)A mRNA Methylation and Gene Transcription by ZFP217 Regulates Pluripotency and Reprogramming.

  2015cites this paper
• Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells

  2015cites this paper
• Correlation of circular RNA abundance with proliferation – exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues

  2015cites this paper
• MiR-203 Suppresses ZNF217 Upregulation in Colorectal Cancer and Its Oncogenicity

  2015cites this paper
• ZNF217 is associated with poor prognosis and enhances proliferation and metastasis in ovarian cancer.

  2014cites this paper
• A functional interplay between ZNF217 and Estrogen Receptor alpha exists in luminal breast cancers

  2014cites this paper
• ZNF 217 , a candidate breast cancer oncogene amplified at 20 q 13 , regulates expression of the ErbB 3 receptor tyrosine kinase in breast cancer cells

  2014cites this paper
• UNIVERSIDADE DE SÃO PAULO FACULDADE DE MEDICINA DE RIBEIRÃO PRETO

  2014cites this paper
• Embryonic stem cell-specific signature in cervical cancer

  2014cites this paper
• Identification of ZNF217, hnRNP‐K, VEGF‐A and IPO7 as targets for microRNAs that are downregulated in prostate carcinoma

  2013cites this paper
• Learning the local Bayesian network structure around the ZNF217 oncogene in breast tumours

  2013cites this paper
• TGF-β-dependent active demethylation and expression of the p15ink4b tumor suppressor are impaired by the ZNF217/CoREST complex.

  2012cites this paper
• Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma

  2012cites this paper
• ZNF217 is a marker of poor prognosis in breast cancer that drives epithelial-mesenchymal transition and invasion.

  2012cites this paper
• The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression.

  2012cites this paper
• The Transcription Factor ZNF 217 Is a Prognostic Biomarker and Therapeutic Target during Breast Cancer Progression

  2012cites this paper
• Kinesin family member 14: An independent prognostic marker and potential therapeutic target for ovarian cancer

  2012cites this paper
• Molecular analysis of the domain with no name (DWNN)/RBBP6 in human cancers

  2012cites this paper
• Overexpression of ZNF217 in glioblastoma contributes to the maintenance of glioma stem cells regulated by hypoxia-inducible factors

  2011cites this paper
• −8p12–23 and +20q Are Predictors of Subtypes and Metastatic Pathways in Colorectal Cancer: Construction of Tree Models Using Comparative Genomic Hybridization Data

  2011cites this paper
• The Significance of PITX2 Overexpression in Human Colorectal Cancer

  2011cites this paper
• Rôle de ZNF217, un nouvel oncogène dans le cancer du sein : rôle dans l’échappement tumoral et valeur pronostique

  2011cites this paper
• DNA Copy Numbers Profiles in Affinity-Purified Ovarian Clear Cell Carcinoma

  2010cites this paper
• Transcriptomic changes arising during light-induced sporulation in Physarum polycephalum

  2010cites this paper
• ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cells

  2010cites this paper
• ZNF217, a candidate breast cancer oncogene amplified at 20q13, regulates expression of the ErbB3 receptor tyrosine kinase in breast cancer cells

  2010cites this paper
• Coexistence of copy number increases of ZNF217 and CYP24A1 in colorectal cancers in a Chinese population.

  2010cites this paper
• eEF1A2 as a Putative Oncogene

  2009cites this paper
• Development of novel agents for ovarian cancer

  2009cites this paper
• Microarray analysis of gene expression in the ovarian cancer cell line HO-8910 with silencing of the ZNF217 gene.

  2009cites this paper
• Silencing of ZNF217 gene influences the biological behavior of a human ovarian cancer cell line.

  2008cites this paper
• Genome-wide DNA copy number predictors of lapatinib sensitivity in tumor-derived cell lines

  2008cites this paper
• The eukaryotic translation elongation factor eEF1A2 induces neoplastic properties and mediates tumorigenic effects of ZNF217 in precursor cells of human ovarian carcinomas

  2008cites this paper
• Revisiting the biological roles of PAI2 (SERPINB2) in cancer

  2008cites this paper
• Ovarian cancer: linking genomics to new target discovery and molecular markers--the way ahead.

  2008cites this paper
• Comprehensive analysis of 20q13 genes in ovarian cancer identifies ADRM1 as amplification target

  2008influential citation
• Genome Analysis Identifies the p15ink4b Tumor Suppressor as a Direct Target of the ZNF217/CoREST Complex

  2008cites this paper
• Amplification of zinc finger gene 217 (ZNF217) and cancer: when good fingers go bad.

  2007cites this paper
• Silencing of ZNF 217 gene influences the biological behavior of a human ovarian cancer cell line

  year unknowncites this paper